fluorohmet (citrate) solution
centre for probe development and commercialization - fludeoxyglucose 18f - solution - 157gbq - fludeoxyglucose 18f 157gbq - roentgenography
glucovision (citrate) solution
centre for probe development and commercialization - fludeoxyglucose 18f - solution - 453gbq - fludeoxyglucose 18f 453gbq - roentgenography
fludeoxyglucose f 18 injection
decatur memorial hospital - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f18 injection, usp is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none. data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data ). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. howeve
fludeoxyglucose f-18 injection
barbara ann karmanos cancer hospital - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f 18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose.
glucovision (phosphate) solution
centre for probe development and commercialization - fludeoxyglucose 18f - solution - 540gbq - fludeoxyglucose 18f 540gbq - roentgenography
flucis solution for injection 250 mbg/ml
cis bio international - fludeoxyglucose (18f) - solution for injection - 250 mbg/ml
fludeoxyglucose f 18- fludeoxyglucose f 18 injection injection
northland nuclear medicine - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f 18 injection,usp is indicated in pet (positron emission tomography) for: 1. identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. 2. assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. 3. assessment of patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging, for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function. fludeoxyglucose f 18 injection, usp is not indicated for distinguishing epileptogenic foci from brain tumors or other brain lesions which may cause seizures. none known
fludeoxyglucose (18f) rtm 200 mbq/ml, injektionslösung
fludeoxyglucose (f-18)
thunder bay regional health sciences centre - fludeoxyglucose 18f - solution - fludeoxyglucose 18f 0.5 gbq / vial - other diagnostic radiopharm. for tumor detection
fludeoxyglucose [f18] injection 5-200 mciml
singapore radiopharmaceuticals pte. ltd. - 2-deoxy-2-[18f]fluoro-d-glucose - injection, solution - 5-200mci/ml - 2-deoxy-2-[18f]fluoro-d-glucose 5-200mci/ml